Support for Psychological Distress Caused by Cancer

Psychological issues such as anxiety disorders, depression, and adjustment disorders are significantly more prevalent among cancer patients during and after treatment compared to the general population. While advancements in medical treatments have led to increased survival rates for cancer patients, many continue to experience substantial psychological challenges for years following their diagnosis.

This disparity was highlighted at a recent oncology-pharmaceutical conference, where an expert in psycho-oncology discussed the importance of addressing the mental health needs of cancer patients. It has been observed that long-term side effects, including fatigue, anxiety, and depression, severely impact the quality of life and treatment adherence, particularly among younger patients, those with lower socioeconomic status, and men lacking partnership support.

A comprehensive epidemiological study involving over 1,000 cancer patients revealed that the prevalence of anxiety disorders, depression, and adjustment disorders is markedly higher than that in the general population--32% at a given time and 40% over a year, compared to 22% to 23% in the general populace. The persistence of depressive symptoms is particularly concerning, as they are linked to poorer treatment outcomes and increased mortality rates.

Despite these challenges, improvements have been made in psycho-oncological care in recent years, thanks to the establishment of cancer counseling centers and standardized screening tools. One such tool, the 'Distress Thermometer,' is a simple, user-friendly scale designed to assess the psychological burden experienced by patients in clinical settings.

Nevertheless, obstacles remain. Many patients with significant mental health needs do not receive timely assistance due to limited resources and extended wait times for psycho-oncological therapies. In addition to traditional counseling and therapy options, digital interventions are gaining traction. Applications like the digital health application (DiGA) 'Mika' and the 'Family Coach Cancer' program from AOK provide scientifically backed support for both patients and their families.

While advancements in screening and counseling structures are notable, the challenge of delivering timely and appropriate support to patients persists. The continued development of evidence-based care models and targeted communication strategies could play a crucial role in enhancing the quality of life for those affected by cancer.